Quantcast
Study Shows Children Who Have Had Enterovirus Infection Are

Study Shows Children Who Have Had Enterovirus Infection Are More Likely To Have Type 1 Diabetes

Provided by Dr. Tsai Chung-Li, Diabetologia A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children who have been infected with enterovirus are 48% more likely to have...

Latest diabetes mellitus Stories

2014-10-22 08:32:25

-- Relamorelin is a Novel Peptide Ghrelin Agonist for Diabetic Gastroparesis -- DUBLIN and BOSTON, Oct. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced that Actavis has been granted an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Health, Inc., which is developing relamorelin (RM-131), a peptide ghrelin agonist, for the treatment of diabetic...

2014-10-22 08:32:22

Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements JERUSALEM, October 22, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today reported positive top-line clinical results from its Phase IIa clinical trial of ORMD-0801, the company's proprietary oral insulin capsules, to treat type 1...

2014-10-22 08:32:13

Company launches The Diabetes Download, a new YouTube channel brought to you by Cornerstones4Care®, to help people living with diabetes incorporate better disease management into their lives. PLAINSBORO, N.J., Oct. 22, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced a new partnership with online sensation Michael Stevens, host and creator of the popular YouTube channel Vsauce, to launch a new 6-part video series, "Breaking Down Diabetes." Stevens, well known for...

2014-10-21 08:34:10

RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults with type 2 diabetes (T2D). Empagliflozin plus metformin is part of the Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) Diabetes alliance portfolio. "Type 2...

2014-10-21 08:33:10

Uppsala University Hospital in Sweden will enroll 8 patients in the study, partially supported by a recent grant by the JDRF ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ -- Beta-O2 announced today that the first patient participating in the company's first broad study of the ssAir Bio-Artificial Pancreas has been successfully implanted. ssAir is in development as a treatment and a potential cure for type 1 diabetes (T1D). Approximately 3 million people have T1D in the...

2014-10-21 08:29:17

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Lazar Partners, a strategic communications firm for companies in the biopharma and medical device space, today announced the firm has been named the recipient of two PR Agency Elite awards by PR News for their work with partner Insulet Corporation on the diabetes blog, Suite D. Lazar Partners was nominated as a finalist and received honorable mention awards in both the Advocacy and Content Marketing categories. Winners were announced at PR...

2014-10-20 23:03:14

DiabetesSisters thanks strategic partner and 2014 Weekend for Women conference Premier Sponsor Sanofi DURHAM, NC (PRWEB) October 20, 2014 The 2014 Weekend for Women is guaranteed to be an event filled with sisterhood, learning opportunities, and community building. It would not be possible without the commitment of attendees and conference presenters, as well as charitable contributions from corporations dedicated to heath-promotion and education. Four days away from the start of the...

2014-10-20 08:31:08

Contrave is now available by prescription, and Contrave patients also have access to the Scale Down program and Direct Save to help support their complete approach to weight management DEERFIELD, Ill. and OSAKA, Japan, Oct. 20, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda"), its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen(®) Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that Contrave(®) (naltrexone HCI and bupropion HCI)...

2014-10-18 23:00:29

North America is the largest contributor to the global market while Asia is expected to grow at the highest rate. http://www.marketsandmarkets.com/Market-Reports/human-insulin-market-229295783.html (PRWEB) October 19, 2014 The “Human Insulin Market- by Product Type, [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2018”...

2014-10-16 12:29:31

Prescribers Are Enthusiastic about the SGLT-2 Inhibitors, but Payers Are Not Fully Convinced of the Added Benefits of These Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 16, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of type 2 diabetes, over 90 percent of surveyed physicians in South Korea and Taiwan indicated that they would use SGLT-2 inhibitors when they become available, and over the next three years these emerging...


Latest diabetes mellitus Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.